Clinical Trials on Von Willebrand Disease, Type 3
Total 62906 results
-
Ruijin HospitalRecruitingNon Hodgkin LymphomaChina
-
Chinese PLA General HospitalRecruitingNon Hodgkin LymphomaChina
-
Zentera Therapeutics HK LimitedTerminated
-
Hoffmann-La RocheCompletedNon-Hodgkin LymphomaAlgeria, Morocco, Tunisia
-
Rhizen Pharmaceuticals SACompletedNon Hodgkin LymphomaUnited States, Australia
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedNon-Hodgkin LymphomaUnited States
-
Soonchunhyang University HospitalCompletedNon-hodgkin LymphomaKorea, Republic of
-
BayerCompleted
-
Sidney Kimmel Cancer Center at Thomas Jefferson...TerminatedNon-Hodgkin LymphomaUnited States
-
Genzyme, a Sanofi CompanyTerminatedNon-Hodgkins LymphomaUnited States
-
University Hospital TuebingenCompleted
-
University Hospital TuebingenCompletedNon-Hodgkin LymphomaGermany
-
Celgene CorporationPrologue Research InternationalCompletedNon-Hodgkins LymphomaUnited States, Canada
-
Gruppo Italiano Multiregionale per lo studio dei...University of Turin, Italy; Fondazione Italiana Linfomi ONLUS; Centro di Riferimento...CompletedLymphoma | Non-Hodgkin LymphomaItaly
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type II | Diabetes Mellitus, Non Insulin DependentUnited States, Poland, Bulgaria, India, Malaysia, Romania, Canada, Russian Federation, Argentina, Puerto Rico, Czech Republic, United Kingdom, Mexico
-
Juventas Cell Therapy Ltd.Not yet recruiting
-
ImmPACT BioRecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
Sun Yat-sen UniversityRecruitingNon-hodgkin LymphomaChina
-
Swiss Group for Clinical Cancer ResearchTerminatedNon-Hodgkin LymphomaSwitzerland
-
Immune DesignMerck Sharp & Dohme LLCTerminatedFollicular Low Grade Non-Hodgkin's Lymphoma
-
Gilead SciencesTerminatedNon-Hodgkin LymphomaUnited States, France
-
University of NebraskaSchering-PloughCompletedNon-Hodgkins LymphomaUnited States
-
ImmunityBio, Inc.Not yet recruitingNon-Hodgkin Lymphoma Refractory/ Relapsed
-
Bristol-Myers SquibbRecruitingRelapsed/Refractory Non-Hodgkin LymphomaUnited States, Spain, France, Netherlands, Switzerland
-
Guangzhou Excelmab Inc.RecruitingSafety and Efficacy of EX103 in Subjects With Relapsed/Refractory CD20-Positive Non-Hodgkin LymphomaCD20-positive Non-Hodgkin LymphomaChina
-
Conjupro Biotherapeutics, Inc.SuspendedCD20 Positive Non Hodgkin LymphomaUnited States
-
Adagene (Suzhou) LimitedTerminatedSolid Tumor | Non Hodgkin LymphomaChina
-
The Christie NHS Foundation TrustTerminatedCD19 Positive Non-Hodgkin LymphomaUnited Kingdom
-
Seoul National University HospitalGyeongsang National University Hospital; Hallym University Medical Center; Kyunghee...TerminatedCD20-positive Non-Hodgkin LymphomaKorea, Republic of
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid CancersUnited States, United Kingdom
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid CancersUnited Kingdom
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid TumorCanada, United States
-
AbbVieGenentech, Inc.WithdrawnRelapsed/Refractory Non-Hodgkin's Lymphoma
-
Assistance Publique - Hôpitaux de ParisCompletedInfantile Spinal Muscular Atrophy of Type 2 or 3France
-
Marker Therapeutics, Inc.RecruitingHodgkin Lymphoma | Non Hodgkin Lymphoma | Hodgkin Lymphoma, Adult | Non-Hodgkin Lymphoma, Adult | Non-Hodgkin Lymphoma, Refractory | Non-Hodgkin Lymphoma, Relapsed | Hodgkin's Lymphoma, Relapsed, AdultUnited States
-
China Medical University HospitalUnknownCondition 1. Children With ALL Are Still Alive and the Age of 18 Years of Age. | Condition 2. Has Been Completed to Guide the Treatment Regimen Were in Remission. | Condition 3. Caregiver Can or Taiwanese Language Communicator.Taiwan
-
Ruijin HospitalNot yet recruitingRelapsed Non-Hodgkin Lymphoma
-
University of Colorado, DenverChildren's Hospital ColoradoRecruitingLeukemia | Non Hodgkin LymphomaUnited States
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaBelgium, France, Italy, Spain, Canada, United States, Bulgaria, United Kingdom, Hungary, Georgia, Belarus, Czechia
-
Sun Yat-sen UniversityCompletedPediatric Non-Hodgkin LymphomaChina
-
Amgen Research (Munich) GmbHCompletedNon-Hodgkin's Lymphoma, RelapsedGermany
-
AstraZenecaTerminatedLymphoma | Non-Hodgkin Lymphoma | NHLUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedTumors | Non-Hodgkins's LymphomaUnited States
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaKorea, Republic of, Czechia, United States, United Kingdom, Italy, Poland, Russian Federation, Germany
-
PfizerCompletedNon-alcoholic SteatohepatitisUnited States, Canada
-
SanofiCompletedLymphoma | Non-HodgkinFrance
-
SanofiCompletedLymphoma | Non-HodgkinUnited States
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of MedicineRecruitingHodgkins Lymphoma | Non Hodgkins LymphomaUnited States
-
University Health Network, TorontoCompletedHodgkin's Lymphoma | Non Hodgkin's LymphomaCanada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed